Corresponding Author: Karina W. Davidson, PhD, MASc, Feinstein Institutes for Medical Research at Northwell Health, 130 E 59th St, Ste 14C, New York, NY 10032 (chair@uspstf.net).
Accepted for Publication: August 4, 2021.
The US Preventive Services Task Force (USPSTF) members: Karina W. Davidson, PhD, MASc; Michael J. Barry, MD; Carol M. Mangione, MD, MSPH; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; Alex H. Krist, MD, MPH; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; James Stevermer, MD, MSPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York (Davidson); Harvard Medical School, Boston, Massachusetts (Barry); University of California, Los Angeles (Mangione); Albert Einstein College of Medicine, New York, New York (Cabana); Oregon Health & Science University, Portland (Caughey); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Chicago, Illinois (Simon); University of Missouri, Columbia (Stevermer); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Davidson had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the US Preventive Services Task Force (USPSTF).
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Kathleen Irwin, MD, MPH (formerly of AHRQ), Tina Fan, MD, MPH (AHRQ), and Brandy Peaker, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force USPSTF makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®–Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2021 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.
5.Reekie
J , Donovan
B , Guy
R ,
et al; Chlamydia and Reproductive Health Outcome Investigators; Chlamydia and Reproductive Health Outcome Investigators. Risk of pelvic inflammatory disease in relation to chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study.
Clin Infect Dis. 2018;66(3):437-443. doi:
10.1093/cid/cix769PubMedGoogle ScholarCrossref 6.American Academy of Pediatrics. Prevention of neonatal ophthalmia. In: Kimberlin
DW , Brady
MT , Jackson
MA , eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. American Academy of Pediatrics; 2018:1047-1102.
8.Stamm
WE . Chlamydia trachomatis infections of the adult. In: Holmes
K , ed. Sexually Transmitted Disease. 4th ed. McGraw-Hill; 2008.
11.McConaghy
JR , Panchal
B . Epididymitis: an overview.
Am Fam Physician. 2016;94(9):723-726.
PubMedGoogle Scholar 13.Fleming
DT , Wasserheit
JN . From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.
Sex Transm Infect. 1999;75(1):3-17. doi:
10.1136/sti.75.1.3PubMedGoogle ScholarCrossref 14.Kalichman
SC , Pellowski
J , Turner
C . Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.
Sex Transm Infect. 2011;87(3):183-190. doi:
10.1136/sti.2010.047514PubMedGoogle ScholarCrossref 17.Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of
Chlamydia trachomatis and
Neisseria gonorrhoeae—2014.
MMWR Recomm Rep. 2014;63(RR-02):1-19.
PubMedGoogle Scholar 19.Cantor
A , Dana
T , Griffen
JC ,
et al. Screening for Chlamydial and Gonococcal Infections: A Systematic Review Update for the US Preventive Services Task Force. Evidence Synthesis No. 206. Agency for Healthcare Research and Quality; 2021. AHRQ publication 21-05275-EF-1.
22.Krist
AH , Davidson
KW , Mangione
CM ,
et al; US Preventive Services Task Force. Screening for hepatitis B virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.
JAMA. 2020;324(23):2415-2422. doi:
10.1001/jama.2020.22980PubMedGoogle Scholar 23.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.
JAMA. 2019;322(4):349-354. doi:
10.1001/jama.2019.9365PubMedGoogle Scholar 24.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.
JAMA. 2020;323(10):970-975. doi:
10.1001/jama.2020.1123PubMedGoogle Scholar 25.Bibbins-Domingo
K , Grossman
DC , Curry
SJ ,
et al; US Preventive Services Task Force. Serologic screening for genital herpes infection: US Preventive Services Task Force recommendation statement.
JAMA. 2016;316(23):2525-2530. doi:
10.1001/jama.2016.16776PubMedGoogle Scholar 26.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Screening for HIV infection: US Preventive Services Task Force recommendation statement.
JAMA. 2019;321(23):2326-2336. doi:
10.1001/jama.2019.6587PubMedGoogle Scholar 27.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement.
JAMA. 2019;321(22):2203-2213. doi:
10.1001/jama.2019.6390PubMedGoogle Scholar 28.Bibbins-Domingo
K , Grossman
DC , Curry
SJ ,
et al; US Preventive Services Task Force (USPSTF). Screening for syphilis infection in nonpregnant adults and adolescents: US Preventive Services Task Force recommendation statement.
JAMA. 2016;315(21):2321-2327. doi:
10.1001/jama.2016.5824PubMedGoogle Scholar 29.Curry
SJ , Krist
AH , Owens
DK ,
et al; US Preventive Services Task Force. Screening for syphilis infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.
JAMA. 2018;320(9):911-917. doi:
10.1001/jama.2018.11785PubMedGoogle Scholar 30.Krist
AH , Davidson
KW , Mangione
CM ,
et al; US Preventive Services Task Force. Behavioral counseling interventions to prevent sexually transmitted infections: US Preventive Services Task Force recommendation statement.
JAMA. 2020;324(7):674-681. doi:
10.1001/jama.2020.13095PubMedGoogle Scholar 32.Cantor
A , Dana
T , Griffen
JC ,
et al. Screening for chlamydial and gonococcal infections: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published September 14, 2021. doi:
10.1001/jama.2021.10577Google Scholar 33.LeFevre
ML ; US Preventive Services Task Force. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;161(12):902-910. doi:
10.7326/M14-1981PubMedGoogle ScholarCrossref 35.Falasinnu
T , Gilbert
M , Gustafson
P , Shoveller
J . A validation study of a clinical prediction rule for screening asymptomatic chlamydia and gonorrhoea infections among heterosexuals in British Columbia.
Sex Transm Infect. 2016;92(1):12-18. doi:
10.1136/sextrans-2014-051992PubMedGoogle ScholarCrossref 40.Berry
L , Stanley
B . Comparison of self-collected meatal swabs with urine specimens for the diagnosis of
Chlamydia trachomatis and
Neisseria gonorrhoeae in men.
J Med Microbiol. 2017;66(2):134-136. doi:
10.1099/jmm.0.000428PubMedGoogle ScholarCrossref 41.Fang
J , Husman
C , DeSilva
L , Chang
R , Peralta
L . Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of
Chlamydia trachomatis and
Neisseria gonorrhoeae in adolescent females.
J Pediatr Adolesc Gynecol. 2008;21(6):355-360. doi:
10.1016/j.jpag.2008.03.010PubMedGoogle ScholarCrossref 42.Nye
MB , Osiecki
J , Lewinski
M ,
et al. Detection of
Chlamydia trachomatis and
Neisseria gonorrhoeae with the cobas CT/NG v2.0 test: performance compared with the BD ProbeTec CT Q
x and GC Q
x amplified DNA and Aptima AC2 assays.
Sex Transm Infect. 2019;95(2):87-93. doi:
10.1136/sextrans-2018-053545PubMedGoogle ScholarCrossref 44.Schoeman
SA , Stewart
CM , Booth
RA , Smith
SD , Wilcox
MH , Wilson
JD . Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study.
BMJ. 2012;345:e8013. doi:
10.1136/bmj.e8013PubMedGoogle Scholar 45.Shrier
LA , Dean
D , Klein
E , Harter
K , Rice
PA . Limitations of screening tests for the detection of
Chlamydia trachomatis in asymptomatic adolescent and young adult women.
Am J Obstet Gynecol. 2004;190(3):654-662. doi:
10.1016/j.ajog.2003.09.063PubMedGoogle ScholarCrossref 47.Stewart
CM , Schoeman
SA , Booth
RA , Smith
SD , Wilcox
MH , Wilson
JD . Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study.
BMJ. 2012;345:e8107. doi:
10.1136/bmj.e8107PubMedGoogle Scholar 48.Sultan
B , White
JA , Fish
R ,
et al. The “3 in 1” study: pooling self-taken pharyngeal, urethral, and rectal samples into a single sample for analysis for detection of
Neisseria gonorrhoeae and
Chlamydia trachomatis in men who have sex with men.
J Clin Microbiol. 2016;54(3):650-656. doi:
10.1128/JCM.02460-15PubMedGoogle ScholarCrossref 49.Oakeshott
P , Kerry
S , Aghaizu
A ,
et al. Randomised controlled trial of screening for
Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention Of Pelvic Infection) trial.
BMJ. 2010;340:c1642. doi:
10.1136/bmj.c1642PubMedGoogle ScholarCrossref 50.Ostergaard
L , Andersen
B , Møller
JK , Olesen
F . Home sampling versus conventional swab sampling for screening of
Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.
Clin Infect Dis. 2000;31(4):951-957. doi:
10.1086/318139PubMedGoogle ScholarCrossref 53.US Preventive Services Task Force. Screening for chlamydial infection—including ocular prophylaxis in newborns. In: Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. US Department of Health and Human Services; 1996.
55.US Preventive Services Task Force. Screening for gonorrhea—including ocular prophylaxis in newborns. In: Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. US Department of Health and Human Services; 1996.